Abstract: One example includes an underwater docking system. The system includes an underwater dock that includes a docking rod. The docking rod includes electrical contacts around a periphery of the docking rod. The system also includes a docking assembly mounted on an underwater vehicle. The docking assembly includes an actuator and a hook assembly that includes a docking arm and a jaw assembly. The docking arm physically guides the docking rod into the jaw assembly and the actuator closes the jaw assembly around the docking rod to provide electrical connection of brush contacts of the jaw assembly with the electrical contacts of the docking rod to provide electrical power from a power source via the electrical contacts to the underwater vehicle. Each of the electrical contacts and the brush contacts can be formed from a self-passivating material.

Abstract: The invention relates to substituted 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) which are agonists of GPR52, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to the 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) for use as a medicament, pharmaceutical compositions comprising the 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) and processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: The invention relates to Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide of formula (I) wherein R1, R2, R3, R5, R6 and A are as defined herein. The compounds of formula (1) are inhibitors of phosphodiesterase 2 and useful in treating central nervous system diseases and other diseases. The invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: A system for testing and/or training the vision of a user is disclosed herein. The system includes at least one camera, a visual display device having an output screen, and a data processing device operatively coupled to the at least one camera and the visual display device. In one embodiment, the data processing device is programmed to determine a head position, head velocity, and/or head speed of a user during a vision test or vision training routine from a plurality of images of the head of the user captured by the at least one camera. In another embodiment, the data processing device is programmed to determine, based upon an input signal received from a user input device, a contrast display setting for a screen background relative to at least one visual target, the contrast display setting enabling the user to gradually adapt to increasing levels of visual stimulation.

Abstract: The invention relates to Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide of general formula (I) which are inhibitors of phosphodiesterase 2, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: The invention relates to 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives of general formula (I) which are agonists of GPR52, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to the 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives of general formula (I) for use as a medicament, pharmaceutical compositions comprising at least a compound of general formula (I) and processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: The invention relates to substituted 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) which are agonists of GPR52, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to the 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) for use as a medicament, pharmaceutical compositions comprising the 3-phenoxyazetidin-1-yl-pyrazines of general formula (I) and processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: A swing analysis system is disclosed herein. The swing analysis system includes a motion capture system and a force measurement assembly configured to receive a user; and at least one data processing device operatively coupled to the motion capture system and the force measurement assembly, the at least one data processing device configured to determine positional information for the one or more body segments of the user from the output data of the at least one motion capture device and output forces and/or moments from the force measurement assembly, the at least one data processing device further configured to determine one or more swing performance parameters for the user using at least one of: (i) the positional information of the one or more body segments of the user from the at least one motion capture device, and (ii) the output forces and/or moments from the force measurement assembly.

Abstract: A measurement system includes a motion capture system comprising at least one motion capture device configured to detect the motion of one or more body portions of a system user and generate output data; a sensory output device, the sensory output device configured to generate sensory feedback for delivery to the system user; and at least one data processing device operatively coupled to the motion capture system and the sensory output device, the at least one data processing device further configured to determine, by utilizing a trained neural network, one or more poses and/or movements of the one or more body portions of the system user from the motion capture output data, and to provide sensory feedback to the system user, by means of the sensory output device, as to conformity of the one or more poses and/or movements to one or more reference poses and/or movements.

Abstract: Machine learning is used to generate a first mipmap of a texture having a first compression based on a second mipmap of the same texture and having a second compression without using compression or decompression in generating the first mipmap. The first mipmap can then be used to render a computer graphics object. Training can be done using as input decompressed blocks from originally compressed blocks.

Abstract: A system for estimating a three dimensional pose and determining one or more biomechanical performance parameters of at least one person in a scene is disclosed herein. The system includes at least one camera and at least one measurement assembly, the at least one camera configured to capture an image of the scene; and a data processor including at least one hardware component, the data processor configured to execute computer executable instructions. The computer executable instructions comprising instructions for: (i) receiving the image of the scene from the at least one camera; (ii) extracting features from the image of the scene for providing inputs to a convolutional neural network; (iii) generating one or more volumetric heatmaps using the convolutional neural network; and (iv) applying a maximization function to the one or more volumetric heatmaps to obtain a three dimensional pose of the at least one person in the scene.

Abstract: Machine learning is used to generate a first mipmap of a texture having a first compression based on a second mipmap of the same texture and having a second compression without using compression or decompression in generating the first mipmap. The first mipmap can then be used to render a computer graphics obj ect.

Abstract: A method for super-resolution of block-compressed texture is provided. The method includes receiving a first texture block of a first block size. Based on application of a first block compression (BC) scheme on the received first texture block, coded-texture values are generated in a compressed domain. Further, a first machine learning model is applied on the generated coded-texture values to generate super-resolution coded-texture values in the compressed domain. The generated super-resolution coded-texture values are processed to generate a second texture block of a second block size. The second block size is greater than the first block size.

Abstract: A swing analysis system is disclosed herein. The swing analysis system includes a force measurement assembly configured to receive a user; and a data processing device operatively coupled to the force measurement assembly, the data processing device is configured to receive one or more signals that are representative of forces and/or moments being applied to a top surface of the force measurement assembly by the user, and to convert the one or more signals into output forces and/or moments, the data processing device is further configured to determine one or more swing performance metrics for the user using the output forces and/or moments from the force measurement assembly.

Abstract: A force measurement system is disclosed herein. The force measurement system includes a force measurement assembly configured to receive a subject thereon, and one or more data processing devices operatively coupled to the force measurement assembly. In one or more embodiments, the one or more data processing devices are operatively coupled to the force measurement assembly, the one or more data processing devices configured to receive one or more signals that are representative of forces and/or moments being applied to a top surface of the force measurement assembly by the subject, and to convert the one or more signals into output forces and/or moments, the one or more data processing devices further configured to predict one or more balance parameters of the subject using a trained neural network.

Abstract: A neurocognitive training system for improving visual motor responses is disclosed herein. The neurocognitive training system includes a user input device configured to output an input signal based upon an input response by the user; a visual display device having an output screen, the visual display device configured to display one or more visual objects on the output screen; and a data processing device, the data processing device operatively coupled to the user input device and the visual display device. The data processing device being programmed to generate and display one or more visual objects on the output screen; receive an input signal from the user input device based upon an input response by the user; and determine, based upon the input signal received from the user input device, whether the user performed a correct action with respect to the one or more visual objects displayed on the output screen.

Abstract: A system for vision testing and/or training of a user is disclosed herein. In one embodiment, the system includes an eye movement tracking device, a visual display device having an output screen, and a data processing device operatively coupled to the eye movement tracking device and the visual display device. The data processing device being programmed to generate and display the at least one visual object on the output screen of the visual display device; displace the at least one visual object across the output screen of the visual display device; and determine, based upon the signal received from the eye movement tracking device, whether the user is able to accurately track the at least one visual object as the at least one visual object is displaced across the output screen of the visual display device.

Abstract: The invention relates to Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide of general formula (I) which are inhibitors of phosphodiesterase 2, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: The invention relates to Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide of general formula (I) which are inhibitors of phosphodiesterase 2, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Abstract: A portable system for vestibular testing and/or training of a user is disclosed herein. The system includes a user input device, the user input device configured to output a signal based upon an input response by the user; a motion sensing device, the motion sensing device configured to measure a velocity or speed of a head of the user; a visual display device, the visual display device configured to display one or more visual objects so that the one or more visual objects are visible to the user; and a data processing device operatively coupled to the user input device, the motion sensing device, and the visual display device. The data processing device is programmed to determine whether or not the user correctly identifies the one or more visual objects displayed on the visual display device based upon the signal from the user input device.